Epion Therapeutics has been granted a new U.S. patent for its novel light therapy device, a core component of the EpiSmart™ Epithelium-On Cross-linking System.

Jonathan H. Talamo, MD, Chair of the Board at Epion Therapeutics, Presents Optometric Survey Results at Eyecelerator @ AAO 2024

“The results of this study demonstrate the promise of our approach to cross-linking in halting the progression of keratoconus in patients and restoring vision with a minimally-invasive process”